A Study on the Efficacy of a Novel Approach to Achieving Laparoscopic Distal Rectal Transection for Rectal Cancers

NCT05067413 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2021-10-05

No results posted yet for this study

Summary

The wide application of ISR and DST has greatly improved the anal preservation rate for low rectal cancers, but the technical difficulty has also been obviously increased because of the limited pelvic space. Although many scholars have tried to solve this problem, all the methods have failed to fundamentally solve the problem of "the oblique dissection" of the distal rectum. To solve the problem above, the director of this clinical trial has explored a new distal rectal resection method-- transanterior obturator nerve gateway approach. The purpose of this clinical trial is to prospectively collect and compare data on the patients' perioperative variables and postoperative functional and oncological outcomes of this novel approach with the traditional approach to confirm the safety and feasibility of this novel approach and its advantages over the traditional approach.

Conditions

  • Rectal Neoplasms Malignant

Interventions

PROCEDURE

Transanterior obturator nerve gateway approach

Distal rectal transection of cases in the experimental group will be performed using transanterior obturator nerve gateway approach

PROCEDURE

Total mesorectal excision approach

Distal rectal transection of cases in the control group will be performed using total mesorectal excision approach

Sponsors & Collaborators

  • Shengli Oilfield Hospital

    collaborator OTHER
  • The Second Affiliated Hospital of Baotou Medical College

    collaborator OTHER
  • Peking University First Hospital

    lead OTHER

Principal Investigators

  • Jianqiang Tang, MD · Peking University First Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-12-01
Completion
2025-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05067413 on ClinicalTrials.gov